aspirin has been researched along with griseofulvin in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (42.31) | 18.7374 |
| 1990's | 4 (15.38) | 18.2507 |
| 2000's | 5 (19.23) | 29.6817 |
| 2010's | 6 (23.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duffy, EM; Jorgensen, WL | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Barber, S; Dew, TP; Farrell, TL; Poquet, L; Williamson, G | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Bazyka, DA | 1 |
| Atkins, CE; Johnson, RK | 1 |
| Jayakrishnan, A; Sunny, MC; Thanoo, BC | 3 |
| Davis, SS | 1 |
| Meyer, MC | 1 |
| Loo, JC; Riegelman, S; Rowland, M | 1 |
| Loo, J; Riegelman, S; Rowland, M | 1 |
| Loo, JC; Riegelman, S | 1 |
| Gibaldi, M | 1 |
| Bacciu, PP; Biglioli, P; Dettori, G; Occhioni, G; Soro, P; Spissu, M; Trignano, M | 1 |
| Becker, JA; Cochran, EB; Phillips, KR; Wideman, SD | 1 |
| COMAISH, JS; SHELLEY, WB | 1 |
| BURNS, JJ; CONNEY, AH; CUCINELL, SA; KOSTER, R | 1 |
2 review(s) available for aspirin and griseofulvin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Clinical toxicities of cats.
Topics: Acetaminophen; Animals; Arsenic Poisoning; Aspirin; Benzoates; Bismuth; Cat Diseases; Cats; Chloramphenicol; Dichlorvos; Diuresis; Ethylene Glycols; Fuel Oils; Gastric Lavage; Griseofulvin; Hexachlorophene; Insecticides; Lead Poisoning; Mercury Poisoning; Methylene Blue; Morphine; Pentobarbital; Phenacetin; Phenols; Plant Poisoning; Rodenticides; Strychnine; Vitamin A | 1975 |
1 trial(s) available for aspirin and griseofulvin
| Article | Year |
|---|---|
[Comparative results of treating lichen ruber planus by various methods].
Topics: Adolescent; Adult; Aged; Aspirin; Bismuth; Child; Child, Preschool; Chloroquine; Chronic Disease; Clinical Trials as Topic; Drug Combinations; Drug Evaluation; Female; Griseofulvin; Humans; Isoniazid; Lichen Planus; Male; Middle Aged; Prednisolone | 1977 |
23 other study(ies) available for aspirin and griseofulvin
| Article | Year |
|---|---|
Prediction of drug solubility from Monte Carlo simulations.
Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Predicting phenolic acid absorption in Caco-2 cells: a theoretical permeability model and mechanistic study.
Topics: Artificial Intelligence; Caco-2 Cells; Cell Membrane Permeability; Cinnamates; Enterocytes; Humans; Hydrophobic and Hydrophilic Interactions; Intestinal Absorption; Kinetics; Models, Biological; Molecular Conformation; Osmolar Concentration; Phenols | 2012 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Cross-linked chitosan microspheres: preparation and evaluation as a matrix for the controlled release of pharmaceuticals.
Topics: Aspirin; Body Fluids; Chitin; Chitosan; Cross-Linking Reagents; Delayed-Action Preparations; Griseofulvin; Microscopy, Electron, Scanning; Microspheres; Particle Size; Theophylline | 1992 |
Scientific principles in design of drug dosage formulations.
Topics: Administration, Oral; Ampicillin; Animals; Aspirin; Barbiturates; Buffers; Capsules; Crystallization; Drug Compounding; Drug Stability; Gastric Mucosa; Griseofulvin; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Methylprednisolone; Oxytetracycline; Salicylamides; Solutions; Suspensions; Tablets; Therapeutic Equivalency; Tolbutamide; Water | 1972 |
Theoretical drug levels during multiple dosing in a two-compartment open model.
Topics: Aspirin; Griseofulvin; Injections, Intravenous; Kinetics; Models, Biological; Pharmaceutical Preparations | 1971 |
Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.
Topics: Aspirin; Griseofulvin; Humans; Injections, Intravenous; Intestinal Absorption; Kinetics; Male; Mannitol; Models, Theoretical; Penicillin G; Pentobarbital; Pharmaceutical Preparations | 1968 |
Concept of a volume of distribution and possible errors in evaluation of this parameter.
Topics: Aspirin; Barbiturates; Griseofulvin; Humans; Injections, Intravenous; Kinetics; Male; Mathematics; Models, Theoretical; Pharmaceutical Preparations; Salicylates | 1968 |
New method for calculating the intrinsic absorption rate of drugs.
Topics: Absorption; Aspirin; Griseofulvin; Humans; Injections, Intravenous; Kinetics; Male; Mathematics; Models, Theoretical; Pharmaceutical Preparations | 1968 |
Effect of mode of administration on drug distribution in a two-compartment open system.
Topics: Anti-Bacterial Agents; Aspirin; Griseofulvin; Injections, Intravenous; Kinetics; Mathematics; Models, Biological; Pharmaceutical Preparations; Salicylates; Time Factors | 1969 |
[Raynaud's phenomenon: diagnostic and therapeutic aspects].
Topics: 1-Propanol; Adult; Aspirin; Ergot Alkaloids; Female; Griseofulvin; Humans; Male; Middle Aged; Raynaud Disease; Sympathectomy; Tetrahydropapaveroline; Vasodilator Agents; Xanthinol Niacinate | 1981 |
Controlled release of oral drugs from cross-linked polyvinyl alcohol microspheres.
Topics: Aspirin; Body Fluids; Chromatography, High Pressure Liquid; Cross-Linking Reagents; Delayed-Action Preparations; Glutaral; Griseofulvin; Microscopy, Electron, Scanning; Microspheres; Niacin; Particle Size; Polyvinyl Alcohol | 1993 |
Oral sustained-release drug delivery systems using polycarbonate microspheres capable of floating on the gastric fluid.
Topics: Aniline Compounds; Aspirin; Body Fluids; Delayed-Action Preparations; Griseofulvin; Microscopy, Electron, Scanning; Microspheres; Particle Size; Polycarboxylate Cement; Stomach | 1993 |
Griseofulvin significantly decreases serum salicylate concentrations.
Topics: Aspirin; Child; Griseofulvin; Humans; Male; Rheumatic Heart Disease; Salicylates; Salicylic Acid; Tinea Capitis | 1993 |
FLUOROMETRIC DETERMINATION OF QUININE AND FLUORESCEIN EXCRETION IN HUMAN SWEAT.
Topics: Aspirin; Biomedical Research; Body Fluids; Chlortetracycline; Fluorescein; Fluoresceins; Fluorescence; Fluorometry; Griseofulvin; Humans; Pharmacology; Quinine; Riboflavin; Sweat | 1965 |
APPLICATION OF DRUG METABOLISM TO DRUG TOXICITY STUDIES.
Topics: Aspirin; Blood; Chromatography; Dicumarol; Diphenhydramine; Dogs; Drug-Related Side Effects and Adverse Reactions; Glutethimide; Griseofulvin; Histamine H1 Antagonists; Liver; Meprobamate; Metabolism; Methylcholanthrene; Pentobarbital; Pharmaceutical Preparations; Phenobarbital; Phenytoin; Piperazines; Probenecid; Rats; Research; Strychnine; Thiopental; Toxicology; Zoxazolamine | 1965 |